Ardelyx Announces FDA Plan to Convene Advisory Committee for XPHOZAH® (tenapanor)
- Ardelyx welcomes the opportunity for the company, patients, and practicing nephrologists to speak to clinically meaningful results in treating hyperphosphatemia - WALTHAM, Mass., April 25, 2022 /PRNewswire/ ...
